Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001161697-22-000027
Filing Date
2022-01-05
Accepted
2022-01-05 15:46:41
Documents
50
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ANNUAL REPORT FOR 09-30-2021 form_10-k.htm   iXBRL 10-K 927701
2 SUBSIDIARIES OF THE REGISTRANT ex_21.htm EX-21 1007
3 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 5861
4 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-2.htm EX-31 5815
5 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3908
6 SECTION 1350 CERTIFICATION ex_32-2.htm EX-32 3862
  Complete submission text file 0001161697-22-000027.txt   4040684

Data Files

Seq Description Document Type Size
7 INLINE XBRL SCHEMA FILE gstc-20210930.xsd EX-101.SCH 26807
8 INLINE XBRL CALCULATION FILE gstc-20210930_cal.xml EX-101.CAL 33964
9 INLINE XBRL DEFINITION FILE gstc-20210930_def.xml EX-101.DEF 140324
10 INLINE XBRL LABEL FILE gstc-20210930_lab.xml EX-101.LAB 257656
11 INLINE XBRL PRESENTATION FILE gstc-20210930_pre.xml EX-101.PRE 208627
44 EXTRACTED XBRL INSTANCE DOCUMENT form_10-k_htm.xml XML 500739
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 206-451-1970
GlobeStar Therapeutics Corp (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-55072 | Film No.: 22510965
SIC: 2834 Pharmaceutical Preparations